Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05516797 · ClinicalTrials.gov registry record · NA
IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 178
- Enrollment target
NCT05516797 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 178 participants.
The verdict
NCT05516797, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 178 participants
- Enrollment target
Study Summary
The purpose of this study is to learn whether there is a difference in the amount of time glucose (blood sugar) stays within a target range (glucose 70 - 180 mg/dl) when using either continuous glucose monitoring (CGM) or fingerstick blood glucose monitoring (BGM) in people with Type 2 diabetes who participate in the Virta Treatment program.
Interventions
- DEVICE Continuous Glucose Monitoring (CGM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2022-09-22 |
| Est. Completion | 2024-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05516797
The ClinicalTrials.gov registry entry for NCT05516797 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitoring (CGM) is the first listed.
NCT05516797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05516797 about?
NCT05516797 is a clinical study titled "IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)". The purpose of this study is to learn whether there is a difference in the amount of time glucose (blood sugar) stays within a target range (glucose 70 - 180 mg/dl) when using either continuous glucose monitoring (CGM) or fingerstick blood glucose monitoring (BGM) in people with Type 2 diabetes who ...
What is the current status of trial NCT05516797?
This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2022-09-22. Estimated completion is 2024-03-01.
What interventions are being tested in trial NCT05516797?
The interventions under investigation include: Continuous Glucose Monitoring (CGM) (DEVICE).
Who is sponsoring clinical trial NCT05516797?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.